Preprint Hypothesis Version 1 This version is not peer-reviewed

Purging Autologous HSCs via Detection of Clonal Mutations

Version 1 : Received: 2 October 2024 / Approved: 2 October 2024 / Online: 2 October 2024 (12:22:05 CEST)

How to cite: Renteln, M. Purging Autologous HSCs via Detection of Clonal Mutations. Preprints 2024, 2024100163. https://doi.org/10.20944/preprints202410.0163.v1 Renteln, M. Purging Autologous HSCs via Detection of Clonal Mutations. Preprints 2024, 2024100163. https://doi.org/10.20944/preprints202410.0163.v1

Abstract

Allogeneic hematopoietic stem cell (HSC) transplants are usually used in cases where patients have active cancerous illness in their bone marrow, but allogeneic transplants can cause graft vs. host disease. If autologous HSCs could be purged of cancer cells, they could then be used for transplantation purposes without concern. It is still controversial whether purging is necessary, but it certainly would alleviate concerns. A novel method of purging is discussed herein that does not require chemotherapy and is targeted for each patient. It could be applied either in vitro or in vivo.

Keywords

purging; autologous bone marrow transplant; hematopoietic stem cells; dual adenoviral transduction; ex vivo and in vivo treatments; personalized oncolytic vector 

Subject

Medicine and Pharmacology, Hematology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.